Alembic intros generic Perforomist
Generic Perforomist provides treatment for bronchoconstriction in patients with COPD, including chronic bronchitis and emphysema.
Alembic is debuting formoterol fumarate inhalation solution, 20 mcg/2 mL per unit-dose vial.
The medication is the generic of Mylan Specialty’s Perforomist.
[Read more: Alembic obtains FDA nod for 2 generics]
The product is a long-acting agonist indicated for long-term, twice daily, administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
Alembic will offer generic Perforomist in 30-count and 60-count units.
[Read more: Alembic launches generic Anafranil]
This is Alembic's first inhalation solution.